Evommune Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Evommune stock has a consensus rating of "Strong Buy" and an average price target of $52.25. The average 1-year stock price forecast is 152.54% higher than the current stock price, while the lowest is $50 (+141.66%) and the highest is $55 (+165.83%).

Price Target: $52.25 (+152.54%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$50	$52.25	$52	$55
Change	+141.66%	+152.54%	+151.33%	+165.83%

Analyst Ratings

The average analyst rating for Evommune stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	4	7	7	7	8	8
Buy	1	1	1	2	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	8	8	9	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mitchell Kapoor H.C. Wainwright	H.C. Wainwright	Buy Reiterates $50	Buy	Reiterates	$50	+141.66%	May 26, 2026
Kostas Biliouris Oppenheimer	Oppenheimer	Buy Reiterates $50	Buy	Reiterates	$50	+141.66%	May 15, 2026
Matt Phipps William Blair	William Blair	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 15, 2026
Brian Abrahams RBC Capital	RBC Capital	Buy Maintains $48 → $50	Buy	Maintains	$48 → $50	+141.66%	May 12, 2026
Judah Frommer Morgan Stanley	Morgan Stanley	Buy Maintains $54 → $55	Buy	Maintains	$54 → $55	+165.83%	May 11, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

6.63M

from 13.00M

-49.04%

from 13.00M

Revenue Next Year

1.77M

from 6.63M

-73.30%

from 6.63M

EPS This Year

-2.76

from -11.22

EPS Next Year

-3.21

from -2.76

Fiscal Year	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	5.00M	7.00M	13.00M	6.63M
Revenue Growth	-	40.00%	85.71%	-49.04%
Gross Profit	5.00M	7.00M	13.00M	6.63M
Gross Margin	100.00%	100.00%	100.00%	100.00%
Operating Income	-37.85M	-70.01M	-81.07M	-106.53M
Net Income	-34.05M	-66.81M	-68.87M	-104.87M
EPS	-	-	-11.22	-2.76
Free Cash Flow	-	-20.45M	-56.17M	-115.00M
No. Analysts	-	-	-	8

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	25.0M
Avg	6.6M
Low	n/a

Revenue Growth

Revenue Growth	2026	2027	2028
High	92.3%
Avg	-49.0%
Low	-100.0%

EPS Forecast

EPS	2026	2027	2028
High	-2.09
Avg	-2.76
Low	-3.30

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-